Cite

MLA Citation

    Ammar Al-Chalabi et al.. “July 2017 ENCALS statement on edaravone.” Amyotrophic lateral sclerosis and frontotemporal degeneration, vol. 18, no. 7, 2017, pp. 471–474. http://access.bl.uk/ark:/81055/vdc_100053607298.0x000012
  
Back to record